Recent News

• 05.01.2025 - First Quarter 2025 Earnings Conference Call
• 04.23.2025 - Phathom Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide Business Update on Thursday, May 1, 2025
• 04.16.2025 - Theodore Schroeder
• 04.16.2025 - Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors
• 04.08.2025 - 24th Annual Needham Virtual Healthcare Conference
• 04.03.2025 - Phathom Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
• 04.01.2025 - Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 04.01.2025 - Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 04.01.2025 - Phathom Pharmaceuticals Announces Leadership Succession
• 04.01.2025 - Phathom Pharmaceuticals Announces Leadership Succession

Recent Filings

• 04.16.2025 - 3 Initial statement of beneficial ownership of securities
• 04.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.16.2025 - 8-K Current report
• 04.08.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.03.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 04.03.2025 - 3 Initial statement of beneficial ownership of securities
• 04.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.01.2025 - 8-K Current report